Article
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.
Clinical lung cancer - 1 Jul 2017
Shen Chan, Kehl Kenneth L, Zhao Bo, Simon George R, Zhou Shouhao, Giordano Sharon H
Abstract excerpt
INTRODUCTION: Epidermal growth factor receptor (EGFR)-targeted therapy significantly improves outcomes among patients with non-small-cell lung cancer (NSCLC) whose tumors harbor sensitizing mutations. Patterns of EGFR testing have not been well-documented. The objective of this population-based study is to assess the testing pattern on a national scale. PATIENTS AND METHODS: Using MarketScan 2012 to 2014 data, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
